thiazoles has been researched along with riluzole in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (10.19) | 18.7374 |
1990's | 88 (81.48) | 18.2507 |
2000's | 2 (1.85) | 29.6817 |
2010's | 5 (4.63) | 24.3611 |
2020's | 2 (1.85) | 2.80 |
Authors | Studies |
---|---|
Chéramy, A; Desmonts, JM; Glowinski, J; Mantz, J; Thierry, AM | 2 |
Blanchard, JC; Doble, A; Hubert, JP | 1 |
Barbeito, L; Chéramy, A; Glowinski, J; Godeheu, G | 1 |
Blin, O; Dusticier, N; Nieoullon, A; Samuel, D | 1 |
Bardot, F; Blanchard, JC; Laduron, PM; Pratt, J; Rataud, J; Roux, M; Stutzmann, JM | 1 |
Benoit, E; Escande, D | 2 |
Gottesmann, C; Lazdunski, M; Romettino, S | 1 |
Becquet, D; Faudon, M; Hery, F | 1 |
Blanchard, JC; Böhme, GA; Gandolfo, G; Gottesmann, C; Laduron, PM; Lafforgue, J; Lazdunski, M; Stutzmann, JM | 1 |
Artaud, F; Barbeito, L; Baruch, P; Chéramy, A; Glowinski, J; Godeheu, G | 1 |
Doble, A; Hubert, JP | 1 |
D'Angio, M; Scatton, B; Serrano, A | 1 |
Blanchard, JC; Cintrat, P; Laduron, PM; Stutzmann, JM | 1 |
Bardot, F; Blanchard, JC; Daniel, M; Laduron, PM; Malgouris, C; Pellis, F; Rataud, J; Uzan, A | 1 |
Blanchard, JC; Laduron, PM; Lucas, M; Stutzmann, JM | 1 |
Koek, W; Woods, JH | 1 |
Baruch, P; Chéramy, A; Glowinski, J; Godeheu, G; Romo, R | 1 |
Benavides, J; Camelin, JC; Flamand, F; Gueremy, C; Le Fur, G; Legrand, JJ; Mitrani, N; Uzan, A | 1 |
Croucher, M; Gueremy, C; Le Fur, G; Legrand, JJ; Mazadier, M; Meldrum, B; Mizoule, J; Ollat, C; Uzan, A | 1 |
Boireau, A; Bordier, F; Doble, A; Dubédat, P | 1 |
Barbeito, L; Estevez, AG; Stutzmann, JM | 1 |
Nightingale, SL | 1 |
Canton, T; Debono, MW; Doble, A; Le Guern, J; Pradier, L | 1 |
Boireau, A; Bordier, F; Doble, A; Dubédat, P; Durand, G; Meunier, M; Miquet, JM; Peny, C | 1 |
Alaoui, F; Court, L; Pratt, J; Stutzmann, JM; Trocherie, S | 1 |
Delumeau, JC; Doble, A; Glowinski, J; Hubert, JP; Prémont, J | 1 |
Heurteaux, C; Lauritzen, I; Lazdunski, M; Widmann, C | 1 |
Daniel, M; Doble, A; Malgouris, C | 1 |
Bousseau, A; Couratier, P; Esclaire, F; Hugon, J; Sindou, P; Yardin, C | 1 |
Boireau, A; Doble, A; Dubédat, P; Meunier, M; Miquet, JM | 1 |
Rowland, LP | 2 |
McRae, KD | 1 |
Burgerman, RS | 1 |
Murphy, JR | 1 |
Rogawski, MA | 1 |
Couratier, P; Esclaire, F; Hugon, J; Louvel, E; Sindou, P | 1 |
Berlioz, S; Brée, F; Nguyen, P; Tillement, JP; Urien, S; Vacherot, F | 1 |
Fuller, GN; McKee, P; Stevens, DL | 1 |
Desmonts, JM; Henzel, D; Laudenbach, V; Lecharny, JB; Mantz, J | 1 |
Ben-Ari, Y; Charriaut-Marlangue, C; Dessi, F | 1 |
Martin, D; Nadler, JV; Thompson, MA | 1 |
Drapeau, P; Dunn, RJ; Hebert, T; Pradier, L | 1 |
Bensimon, G; Lacomblez, L; Meininger, V | 1 |
Allix, M; Boulu, RG; Plotkine, M; Wahl, F | 1 |
Benazzouz, A; Boireau, A; Boraud, T; Dubédat, P; Gross, C; Stutzmann, JM | 1 |
Bensimon, G; Guillet, P; Lacomblez, L; Leigh, PN; Meininger, V | 1 |
Emami, J; Goonetilleke, A; Guiloff, RJ | 1 |
Martí-Fàbregas, J | 1 |
Berger, AJ; Umemiya, M | 1 |
Boraud, T; Gross, C; Pratt, J; Stutzmann, JM | 1 |
Andrus, PK; Cutting, FB; Gurney, ME; Hall, ED; Zhai, P | 1 |
Festoff, BW | 1 |
Wokke, J | 1 |
Mary, V; Stutzmann, JM; Wahl, F | 1 |
Amagasu, SM; MacIver, MB; Mikulec, AA; Monroe, FA | 1 |
Bouchard, JP; Duquette, P; Eisen, A; Gelinas, D; Harati, Y; Miller, RG; Munsat, TL; Powe, L; Rothstein, J; Salzman, P; Sufit, RL | 1 |
Newman, D; Sufit, R | 1 |
Hugon, J | 1 |
Benfield, P; Bryson, HM; Fulton, B | 1 |
Barnéoud, P; Boireau, A; Doble, A; Dubédat, P; Mazadier, M; Miquet, JM; Parmentier, S | 1 |
Hobbs, GR; Riggs, JE | 1 |
Doble, A | 1 |
Bensimon, G; Delumeau, JC; Durrleman, S; Guillet, P; Lacomblez, L; Leigh, PN; Meininger, V; Powe, L | 1 |
Barnes, S | 1 |
Reynolds, DJ | 1 |
Andrus, PK; Cutting, FB; Doble, A; Gurney, ME; Hall, ED; Taylor, CP; Zhai, P | 1 |
Wokke, JH | 1 |
Obrenovitch, TP | 1 |
McIntosh, TK; Perri, BR; Smith, DH; Stutzmann, JM; Voddi, M | 1 |
Klivényi, P; Vécsei, L | 1 |
Moriwaka, F | 1 |
Bansinath, M; Nivarthi, RN; Turndorf, H | 1 |
Andersen, PM; Forsgren, L; Sojka, P | 1 |
Bernardi, G; Bonci, A; Mercuri, NB; Siniscalchi, A | 1 |
Klappenbach, G; Ludolph, AC; Riepe, MW | 1 |
Shindo, M; Yanagisawa, N | 1 |
Scarlato, G | 1 |
Ince, PG; Shaw, PJ | 1 |
Aubin, F; Dib, M; Jourdain, G; Meininger, V; Zeisser, P | 1 |
Dengler, R; Tröger, M | 1 |
Landis, BE; Wagner, ML | 1 |
Mitsumoto, H | 1 |
Mary, V; Renou, E; Stutzmann, JM; Wahl, F | 1 |
Clark, W; Kendall, MJ | 1 |
Barbeito, L; Estevez, A; Peluffo, H; Stutzmann, JM | 1 |
Brouillet, E; Guyot, MC; Hantraye, P; Mary, V; Palfi, S; Peschanski, M; Riche, D; Stutzmann, JM; Wahl, F | 1 |
Huang, CS; Nagata, K; Narahashi, T; Song, JH; Twombly, D; Yeh, JZ | 1 |
Huang, CS; Nagata, K; Narahashi, T; Song, JH; Yeh, JZ | 2 |
Bernardi, G; Spadoni, F; Stefani, A | 1 |
Bournique, B; Martinet, M; Petry, M; Sanderink, GJ; Stevens, J | 1 |
Audiau, F; Barreau, M; Blanchard, JC; Boireau, A; Bour, Y; Coléno, MA; Doble, A; Doerflinger, G; Donat, MH; Duchesne, JM; Ganil, P; Gontier, S; Guérémy, C; Honor, E; Hubert, P; Huu, CD; Jimonet, P; Just, B; Kerphirique, R; Laduron, PM; Le Blevec, J; Meunier, M; Mignani, S; Miquet, JM; Nemecek, C | 1 |
Bloch, DA; Ciraulo, AM; Ciraulo, DA; Elkashef, A; Knapp, CM; Leiderman, DB; LoCastro, J; Montgomery, MA; Sarid-Segal, O | 1 |
Barker, AL; Bates, GP; Beunard, JL; Hockly, E; Holt, K; Lowden, PA; Moffitt, H; Moolman, DL; Revington, AP; Sathasivam, K; Sunshine, S; Tse, J; Wanker, EE; Woodman, B | 1 |
Deng, Y; Feng, W; Liu, W; Tian, Y; Xu, B; Xu, D; Xu, Z; Yang, H | 1 |
Bruno, C; Camerino, DC; Carbonara, R; Cavalluzzi, MM; Costanza, T; Desaphy, JF; Franchini, C; Lentini, G | 1 |
Carbonara, R; Conte Camerino, D; Costanza, T; Desaphy, JF | 1 |
Altamura, C; Desaphy, JF; Farinato, A | 1 |
Scott, A | 1 |
van Den Berg, LH; van Eijk, RPA | 1 |
Chen, JJ | 1 |
16 review(s) available for thiazoles and riluzole
Article | Year |
---|---|
Amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Excitatory Amino Acid Antagonists; Humans; Immunization, Passive; Motor Neuron Disease; Neurologic Examination; Riluzole; Thiazoles | 1994 |
Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Topics: Amyotrophic Lateral Sclerosis; Animals; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 21; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Mutation; Riluzole; Superoxide Dismutase; Thiazoles; Vitamin E | 1996 |
Amyotrophic lateral sclerosis: current and future treatment strategies.
Topics: Amyotrophic Lateral Sclerosis; Apoptosis; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Humans; Insulin-Like Growth Factor I; Nerve Tissue Proteins; Riluzole; Thiazoles | 1996 |
Riluzole.
Topics: Amyotrophic Lateral Sclerosis; Animals; Drug Interactions; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Neuroprotective Agents; Riluzole; Thiazoles | 1996 |
Riluzole and ALS therapy.
Topics: Amyotrophic Lateral Sclerosis; Double-Blind Method; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Motor Neurons; Neurologic Examination; Riluzole; Survival Analysis; Thiazoles | 1996 |
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Excitatory Amino Acid Antagonists; Humans; In Vitro Techniques; Mice; Motor Neuron Disease; Multicenter Studies as Topic; Neuroprotective Agents; Randomized Controlled Trials as Topic; Riluzole; Sodium Channels; Thiazoles; Treatment Outcome | 1996 |
The pharmacology and mechanism of action of riluzole.
Topics: Animals; Excitatory Amino Acid Antagonists; Rats; Riluzole; Thiazoles | 1996 |
Sodium and potassium channel modulators: their role in neuroprotection.
Topics: Animals; Benzeneacetamides; Cell Survival; Disease Models, Animal; Lamotrigine; Neurons; Neuroprotective Agents; Piperazines; Piperidines; Potassium Channels; Pyrimidines; Riluzole; Sodium Channels; Thiazoles; Triazines | 1997 |
[Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities].
Topics: Aged; Aging; Alzheimer Disease; Calcium Channel Blockers; Cerebellar Diseases; Dementia; Electron Transport; Female; Humans; Huntington Disease; Lamotrigine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Riluzole; Thiazoles; Triazines | 1997 |
[Amyotrophic lateral sclerosis].
Topics: Adult; Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Animals; Autoimmunity; Double-Blind Method; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Nerve Growth Factors; Nerve Tissue Proteins; Point Mutation; Randomized Controlled Trials as Topic; Riluzole; Superoxide Dismutase; Thiazoles; Threonine | 1997 |
Glutamate, excitotoxicity and amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Neuroprotective Agents; Receptors, Glutamate; Riluzole; Thiazoles | 1997 |
Impact of riluzole on the relationship between patient and physician.
Topics: Amyotrophic Lateral Sclerosis; Attitude; Disease Progression; Emotions; Humans; Neuroprotective Agents; Physician-Patient Relations; Physicians; Riluzole; Thiazoles | 1997 |
Riluzole: a new agent for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Drug Interactions; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Riluzole; Thiazoles | 1997 |
Therapeutic advances: riluzole for the treatment of motor neurone disease.
Topics: Amyotrophic Lateral Sclerosis; Asthenia; Excitatory Amino Acid Antagonists; Health Care Costs; Humans; Quality of Life; Riluzole; Survivors; Thiazoles; Treatment Outcome | 1996 |
Riluzole for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Riluzole; Thiazoles | 1997 |
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels.
Topics: Animals; Humans; Myotonia; Piperidines; Riluzole; Thiazoles; Voltage-Gated Sodium Channels | 2018 |
9 trial(s) available for thiazoles and riluzole
Article | Year |
---|---|
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Riluzole; Survival Analysis; Thiazoles; Treatment Outcome | 1994 |
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
Topics: Amyotrophic Lateral Sclerosis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroprotective Agents; Prognosis; Proportional Hazards Models; Riluzole; Survival Analysis; Thiazoles; Time Factors; Tracheostomy; Treatment Outcome | 1996 |
Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.
Topics: Adult; Amyotrophic Lateral Sclerosis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Neuroprotective Agents; Riluzole; Thiazoles | 1996 |
Riluzole and ALS therapy.
Topics: Amyotrophic Lateral Sclerosis; Double-Blind Method; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Motor Neurons; Neurologic Examination; Riluzole; Survival Analysis; Thiazoles | 1996 |
A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.
Topics: Amyotrophic Lateral Sclerosis; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Riluzole; Survival Analysis; Thiazoles | 1996 |
Effects of riluzole on symptom progression in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Riluzole; Thiazoles | 1997 |
Increase of flexor reflex latency in patients with amyotrophic lateral sclerosis treated with riluzole.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Reaction Time; Reflex, Stretch; Riluzole; Thiazoles | 1997 |
The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.
Topics: Aged; Amyotrophic Lateral Sclerosis; Female; France; Humans; Male; Middle Aged; Neuroprotective Agents; Riluzole; Risk; Survival Analysis; Thiazoles; Time Factors; Tracheostomy; Treatment Failure; Treatment Outcome | 1997 |
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
Topics: Adolescent; Adult; Antidepressive Agents; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Paroxetine; Pentoxifylline; Phosphodiesterase Inhibitors; Pramipexole; Riluzole; Selective Serotonin Reuptake Inhibitors; Thiazoles; Venlafaxine Hydrochloride | 2005 |
84 other study(ies) available for thiazoles and riluzole
Article | Year |
---|---|
Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission.
Topics: Anesthetics; Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Injections, Intraperitoneal; Ketamine; Male; Rats; Rats, Inbred Strains; Reflex, Abnormal; Riluzole; Sleep; Synaptic Transmission; Thiazoles; Thiopental | 1992 |
Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells.
Topics: Anesthetics; Aspartic Acid; Carbachol; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Humans; Pertussis Toxin; Riluzole; Thiazoles; Virulence Factors, Bordetella | 1992 |
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Topics: Amino Acids; Anesthetics; Animals; Aspartic Acid; Calcium; Cats; Caudate Nucleus; Female; Glutamates; Glutamic Acid; Male; Potassium; Riluzole; Thiazoles | 1992 |
Effects of riluzole (2-amino-6-trifluoromethoxy benzothiazole) on striatal neurochemical markers in the rat, with special reference to the dopamine, choline, GABA and glutamate synaptosomal high affinity uptake systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Culture Media; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hydroxyindoleacetic Acid; Neurotransmitter Uptake Inhibitors; Rats; Rats, Wistar; Riluzole; Serotonin; Synaptic Transmission; Synaptosomes; Thiazoles; Tritium | 1992 |
Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Electroencephalography; Gerbillinae; Ischemic Attack, Transient; Male; Rats; Riluzole; Thiazoles | 1992 |
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Topics: Animals; In Vitro Techniques; Kinetics; Models, Biological; Nerve Fibers; Potassium Channels; Rana esculenta; Ranvier's Nodes; Riluzole; Sodium Channels; Thiazoles | 1991 |
Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Circadian Rhythm; Disease Models, Animal; Electromyography; Epilepsy, Absence; Male; Rats; Rats, Inbred Strains; Riluzole; Sleep; Thiazoles; Wakefulness | 1991 |
In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Aspartic Acid; Bicuculline; Cats; Caudate Nucleus; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Male; N-Methylaspartate; Neurons; Riluzole; Serotonin; Spinal Cord; Synaptic Transmission; Tetrodotoxin; Thiazoles | 1990 |
Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Elapid Venoms; Electroencephalography; Hippocampus; Injections, Intraventricular; Male; Peptides; Rats; Rats, Inbred Strains; Riluzole; Seizures; Thiazoles | 1991 |
Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Topics: Animals; Cats; Corpus Striatum; Dendrites; Dopamine; Female; Glutamates; Glutamic Acid; Male; Nerve Endings; Neurokinin A; Neuropeptides; Riluzole; Substance P; Substantia Nigra; Thiazoles | 1988 |
Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells.
Topics: Amino Acids; Animals; Aspartic Acid; Cells, Cultured; Cerebellum; Ibotenic Acid; Oxazoles; Phosphoserine; Rats; Receptors, Amino Acid; Receptors, Cell Surface; Riluzole; Thiazoles | 1989 |
[Anesthetic properties of a new inhibitor of glutaminergic transmission in the central nervous system, riluzole].
Topics: Anesthetics; Animals; Central Nervous System; Glutamine; Male; Rats; Rats, Inbred Strains; Riluzole; Synaptic Transmission; Thiazoles | 1989 |
NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Aspartic Acid; Carbolines; Convulsants; Diazepam; Male; N-Methylaspartate; Nucleus Accumbens; Phenylacetates; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Restraint, Physical; Riluzole; Septal Nuclei; Thiazoles | 1989 |
Riluzole antagonizes the anxiogenic properties of the beta-carboline FG 7142 in rats.
Topics: Animals; Anti-Anxiety Agents; Appetite Depressants; Carbolines; Conditioning, Operant; Male; Rats; Rats, Inbred Strains; Riluzole; Thiazoles | 1989 |
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
Topics: Amnesia; Animals; Avoidance Learning; Excitatory Amino Acid Antagonists; Female; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Memory; Neurons; Quinuclidinyl Benzilate; Receptors, Muscarinic; Riluzole; Thiazoles | 1989 |
Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats.
Topics: Animals; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, Neurotransmitter; Riluzole; Sleep; Sleep, REM; Thiazoles; Time Factors | 1988 |
2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Topics: Animals; Behavior, Animal; Catalepsy; Columbidae; Discrimination Learning; Macaca mulatta; Male; Mephenesin; Phencyclidine; Rats; Rats, Inbred Strains; Riluzole; Species Specificity; Synaptic Transmission; Thiazoles | 1988 |
In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.
Topics: Animals; Caudate Nucleus; Cerebral Cortex; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Male; Neural Pathways; Rats; Receptors, Glutamate; Receptors, Neurotransmitter; Riluzole; Synaptic Transmission; Tetrodotoxin; Thiazoles | 1986 |
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.
Topics: Acetylcholine; Amino Acids; Animals; Anticonvulsants; Apomorphine; Cerebellum; Chlordiazepoxide; Cyclic GMP; Diazepam; gamma-Aminobutyric Acid; Harmaline; In Vitro Techniques; Injections, Intraventricular; Isoniazid; Male; Rats; Rats, Inbred Strains; Riluzole; Synaptic Transmission; Thiazoles | 1985 |
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Topics: Amino Acids; Animals; Anticonvulsants; Bicuculline; Electroshock; Female; Glutamate Decarboxylase; Harmaline; Male; Mice; Mice, Inbred DBA; Ouabain; Papio; Pentylenetetrazole; Picrotoxin; Rats; Riluzole; Seizures; Synaptic Transmission; Thiazoles | 1985 |
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Lamotrigine; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neostriatum; Neurons; Riluzole; Sodium Channels; Synaptic Transmission; Thiazoles; Triazines | 1995 |
Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cell Survival; Cells, Cultured; Central Nervous System Diseases; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Glutamic Acid; Kainic Acid; Motor Neurons; N-Methylaspartate; Rats; Receptors, Amino Acid; Riluzole; Thiazoles | 1995 |
Riluzole for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Muscles; Riluzole; Sodium Channels; Thiazoles; Tracheostomy; Treatment Outcome | 1995 |
From the Food and Drug Administration.
Topics: Amyotrophic Lateral Sclerosis; Drug Labeling; Drugs, Investigational; Humans; Product Surveillance, Postmarketing; Riluzole; Theophylline; Thiazoles; United States; United States Food and Drug Administration | 1995 |
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Topics: 2-Amino-5-phosphonovalerate; Animals; Electrophysiology; Female; In Vitro Techniques; Ion Channels; Kainic Acid; Oocytes; Radioligand Assay; Rats; Receptors, N-Methyl-D-Aspartate; Riluzole; RNA, Messenger; Synaptic Transmission; Thiazoles; Xenopus laevis | 1993 |
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Riluzole; Thiazoles | 1994 |
Acute effects of irradiation on the rat brain: protection by glutamate blockade.
Topics: Amifostine; Animals; Brain; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Motor Activity; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Riluzole; Thiazoles | 1995 |
Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Cerebellum; Cytosol; Excitatory Amino Acid Antagonists; Fluorescent Dyes; GTP-Binding Proteins; Indoles; N-Methylaspartate; Neuromuscular Depolarizing Agents; Neurons; Rats; Receptors, Glutamate; Riluzole; Sodium Channels; Spectrometry, Fluorescence; Thiazoles; Veratridine | 1994 |
Glutamate-induced overexpression of NMDA receptor messenger RNAs and protein triggered by activation of AMPA/kainate receptors in rat hippocampus following forebrain ischemia.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Base Sequence; Brain Ischemia; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; Molecular Sequence Data; Oligonucleotide Probes; Prosencephalon; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Riluzole; RNA, Messenger; Thiazoles | 1994 |
Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices.
Topics: Animals; Cell Death; Female; Hippocampus; L-Lactate Dehydrogenase; Male; N-Methylaspartate; Nerve Tissue Proteins; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Riluzole; Sodium Channels; Thiazoles; Veratridine; Virulence Factors, Bordetella | 1994 |
Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; HIV Envelope Protein gp120; HIV-1; Nerve Degeneration; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Riluzole; Thiazoles | 1994 |
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Homovanillic Acid; Male; Parkinson Disease, Secondary; Rats; Riluzole; Thiazoles | 1994 |
Riluzole in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Research Design; Riluzole; Thiazoles | 1994 |
Riluzole in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Riluzole; Thiazoles | 1994 |
Riluzole in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Excitatory Amino Acid Antagonists; Humans; Research Design; Riluzole; Thiazoles | 1994 |
Riluzole in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Research Support as Topic; Riluzole; Thiazoles | 1994 |
Neuroprotective effects of riluzole in ALS CSF toxicity.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cells, Cultured; Excitatory Amino Acid Antagonists; Humans; Neurons; Neurotoxins; Rats; Receptors, Glutamate; Riluzole; Thiazoles | 1994 |
Characterization of discrete classes of binding sites of human serum albumin by application of thermodynamic principles.
Topics: Benzothiazoles; Binding Sites; Humans; Isradipine; Ligands; Riluzole; Serum Albumin; Sulfonamides; Thermodynamics; Thiazoles | 1994 |
Riluzole in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Riluzole; Thiazoles | 1994 |
Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes.
Topics: Animals; Corpus Striatum; Excitatory Amino Acid Antagonists; GABA Antagonists; Male; Rats; Rats, Wistar; Riluzole; Synaptosomes; Thiazoles | 1994 |
Riluzole prevents anoxic injury in cultured cerebellar granule neurons.
Topics: Animals; Cells, Cultured; Cerebellum; Hypoxia, Brain; Nerve Degeneration; Neurons; Rats; Riluzole; Synaptic Transmission; Thiazoles | 1993 |
The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.
Topics: Animals; Aspartic Acid; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Potassium; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Riluzole; Thiazoles | 1993 |
Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.
Topics: Animals; Brain Ischemia; Models, Neurological; Neuropeptides; Oocytes; Rats; Riluzole; Sodium Channel Blockers; Sodium Channels; Thiazoles; Xenopus | 1994 |
Riluzole for the treatment of amyotrophic lateral sclerosis--too soon to tell?
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Riluzole; Thiazoles | 1994 |
Effect of riluzole on focal cerebral ischemia in rats.
Topics: Anesthetics; Animals; Avoidance Learning; Blood Pressure; Brain; Brain Ischemia; Male; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Riluzole; Thiazoles | 1993 |
Fast K channels are more sensitive to riluzole than slow K channels in myelinated nerve fibre.
Topics: Anesthetics; Animals; In Vitro Techniques; Nerve Fibers, Myelinated; Potassium Channels; Potassium Chloride; Psychotropic Drugs; Rana esculenta; Ranvier's Nodes; Riluzole; Sciatic Nerve; Thiazoles | 1993 |
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.
Topics: Animals; Antiparkinson Agents; Dopamine; Electromyography; Excitatory Amino Acid Antagonists; Macaca mulatta; MPTP Poisoning; Muscle Rigidity; Neuroprotective Agents; Parkinson Disease, Secondary; Pilot Projects; Riluzole; Sodium Channels; Thiazoles | 1995 |
Riluzole and amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Humans; Neuroprotective Agents; Patient Dropouts; Proportional Hazards Models; Reproducibility of Results; Riluzole; Risk; Thiazoles | 1996 |
[Riluzole for everybody or for nobody].
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Riluzole; Thiazoles | 1996 |
Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones.
Topics: Animals; Animals, Newborn; Glycine Agents; Hypoglossal Nerve; In Vitro Techniques; Ion Channels; Motor Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Riluzole; Synaptic Transmission; Tetrodotoxin; Thiazoles | 1995 |
The effect of riluzole on post-traumatic spinal cord injury in the rat.
Topics: Anesthesia; Animals; Evoked Potentials, Somatosensory; Hemorrhage; Male; Neuroprotective Agents; Paralysis; Rats; Rats, Wistar; Riluzole; Spinal Cord; Spinal Cord Compression; Thiazoles; Time Factors | 1996 |
Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission.
Topics: Animals; Anticonvulsants; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Lamotrigine; Male; Neurons; Quinolinic Acid; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Riluzole; Synaptic Transmission; Thiazoles; Triazines | 1995 |
Riluzole anesthesia: use-dependent block of presynaptic glutamate fibers.
Topics: Action Potentials; Anesthetics; Animals; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Riluzole; Sodium Channel Blockers; Synaptic Transmission; Thiazoles | 1996 |
The impact of the approval of riluzole.
Topics: Amyotrophic Lateral Sclerosis; Humans; Neuroprotective Agents; Riluzole; Thiazoles | 1996 |
Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Double-Blind Method; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Riluzole; Survival Analysis; Thiazoles; Tracheostomy | 1996 |
Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apomorphine; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Agonists; Female; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Riluzole; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Thiazoles | 1996 |
Riluzole and amyotrophic lateral sclerosis: did potential market size bias pharmaceutical research?
Topics: Amyotrophic Lateral Sclerosis; Drug Industry; Humans; Neuroprotective Agents; Riluzole; Thiazoles | 1996 |
Riluzole.
Topics: Aged; Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Humans; Neuroprotective Agents; Publishing; Riluzole; Thiazoles | 1996 |
Riluzole.
Topics: Humans; Motor Neuron Disease; Neuroprotective Agents; Prognosis; Riluzole; Thiazoles | 1996 |
Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Animals; Brain; Cyclohexanecarboxylic Acids; Diet; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Mice; Mice, Transgenic; Oxidative Stress; Riluzole; Spinal Cord; Superoxide Dismutase; Survival Analysis; Thiazoles; Vitamin E | 1996 |
[Riluzole treatment in amyotrophic lateral sclerosis].
Topics: Amyotrophic Lateral Sclerosis; Controlled Clinical Trials as Topic; Drug Costs; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Riluzole; Thiazoles | 1996 |
Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat.
Topics: Animals; Body Water; Brain Edema; Brain Injuries; Cognition Disorders; Male; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Riluzole; Thiazoles | 1996 |
Role of nitric oxide-mediated signal transduction in hypothermia induced by intravenous anesthetics.
Topics: Anesthetics, Intravenous; Animals; Cerebellum; Cyclic GMP; Hypothermia; Ketamine; Mice; Nitric Oxide; Nitric Oxide Synthase; Pentobarbital; Proto-Oncogene Proteins c-fos; Riluzole; Signal Transduction; Thiazoles | 1997 |
Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study.
Topics: Action Potentials; Animals; Calcium; Cerebral Cortex; Glutamic Acid; In Vitro Techniques; Male; Neuroprotective Agents; Rats; Rats, Wistar; Riluzole; Thiazoles | 1997 |
[Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Topics: Amyotrophic Lateral Sclerosis; Humans; Neuroprotective Agents; Riluzole; Thiazoles | 1996 |
Amyotrophic lateral sclerosis: from pathological mechanisms to patient care.
Topics: Amyotrophic Lateral Sclerosis; Animals; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Point Mutation; Riluzole; Superoxide Dismutase; Thiazoles | 1997 |
Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis?
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Neuroprotective Agents; Riluzole; Thiazoles | 1997 |
Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury.
Topics: Animals; Brain; Brain Injuries; Male; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Riluzole; Thiazoles; Wounds, Nonpenetrating | 1997 |
Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyte monolayers.
Topics: Animals; Astrocytes; Cell Survival; Cells, Cultured; Culture Media, Conditioned; DNA; Immunohistochemistry; Leucine; Motor Neurons; Nerve Tissue Proteins; Neuroprotective Agents; Rats; Receptors, Nerve Growth Factor; Riluzole; Spinal Cord; Thiazoles; Thymidine | 1997 |
Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
Topics: Acetylcholinesterase; Animals; Antiparkinson Agents; Apomorphine; Caudate Nucleus; Corpus Striatum; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Papio; Parkinson Disease, Secondary; Propionates; Putamen; Riluzole; Thiazoles | 1997 |
G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons.
Topics: Animals; Animals, Newborn; Calcium Channels; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Ethylmaleimide; Ganglia, Spinal; GTP-Binding Proteins; Guanosine Diphosphate; Ion Channel Gating; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Riluzole; Thiazoles; Thionucleotides; Virulence Factors, Bordetella | 1997 |
Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels.
Topics: Animals; Female; Ganglia, Spinal; In Vitro Techniques; Kinetics; Male; Neurons; Neuroprotective Agents; Rats; Riluzole; Sodium Channel Blockers; Sodium Channels; Tetrodotoxin; Thiazoles | 1997 |
Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies.
Topics: Animals; Anticonvulsants; Calcium; Calcium Channel Blockers; Cerebral Cortex; Electric Conductivity; Excitatory Amino Acid Antagonists; Lamotrigine; Male; Neurons; Neuroprotective Agents; Phenytoin; Rats; Rats, Wistar; Riluzole; Sodium; Thiazoles; Triazines | 1997 |
Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Humans; Neurology; Riluzole; Societies, Medical; Thiazoles; Treatment Outcome | 1997 |
Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Ganglia, Spinal; Neuroprotective Agents; Nimodipine; Rats; Rats, Sprague-Dawley; Riluzole; Thiazoles | 1997 |
Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro.
Topics: Biotransformation; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Glucuronates; Humans; Isoenzymes; Male; Neuroprotective Agents; Oxidation-Reduction; Riluzole; Thiazoles | 1997 |
Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines.
Topics: Animals; Benzothiazoles; Excitatory Amino Acid Antagonists; Glutamic Acid; Hypoxia; Imines; Injections, Intraventricular; Male; Mice; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Riluzole; Seizures; Structure-Activity Relationship; Sulfoxides; Thiazoles | 1999 |
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
Topics: Animals; Benzothiazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Genotype; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neuroprotective Agents; Organ Culture Techniques; Riluzole; Thiazoles | 2006 |
G0/G1 phase arrest and apoptosis induced by manganese chloride on cultured rat astrocytes and protective effects of riluzole.
Topics: Animals; Animals, Newborn; Apoptosis; Astrocytes; Cell Cycle; Cell Cycle Checkpoints; Cell Survival; Cells, Cultured; Chlorides; Coloring Agents; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; L-Lactate Dehydrogenase; Manganese Compounds; Manganese Poisoning; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Resting Phase, Cell Cycle; Riluzole; Tetrazolium Salts; Thiazoles | 2011 |
Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.
Topics: Anesthetics, Local; Binding Sites; Cell Line; HEK293 Cells; Humans; Membrane Potentials; Membrane Proteins; Mutation; NAV1.4 Voltage-Gated Sodium Channel; Neuroprotective Agents; Piperidines; Protein Binding; Protein Interaction Domains and Motifs; Protein Isoforms; Riluzole; Sodium Channel Blockers; Thiazoles | 2013 |
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Topics: Animals; Carbamazepine; Disease Models, Animal; Flecainide; HEK293 Cells; Humans; Mexiletine; Muscle, Skeletal; Myotonia Congenita; Orphenadrine; Piperidines; Propafenone; Rats; Rats, Wistar; Riluzole; Sodium Channel Blockers; Thiazoles | 2014 |
Drug therapy: On the treatment trail for ALS.
Topics: Amyotrophic Lateral Sclerosis; Antipyrine; Benzamides; C9orf72 Protein; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Edaravone; Genetic Therapy; Humans; Imidazoles; Mesenchymal Stem Cells; Motor Neurons; Neuroglia; Off-Label Use; Oligoribonucleotides, Antisense; Piperidines; Precision Medicine; Pyrazines; Pyridines; Riluzole; RNAi Therapeutics; Stem Cell Transplantation; Superoxide Dismutase; Thiazoles; United States; United States Food and Drug Administration | 2017 |
In pursuit of the normal progressor: the holy grail for ALS clinical trial design?
Topics: Amyotrophic Lateral Sclerosis; Benzamides; Clinical Trials as Topic; Humans; Piperidines; Pyridines; Riluzole; Thiazoles | 2020 |
Overview of current and emerging therapies for amytrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Antibodies, Monoclonal, Humanized; Benzamides; Edaravone; Humans; Mesenchymal Stem Cells; Oligonucleotides; Piperidines; Pyridines; Riluzole; Thiazoles | 2020 |